{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:54:48Z","timestamp":1740164088955,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022612","name":"Ministero della Difesa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78381-8","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T01:10:50Z","timestamp":1735348250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative IgG response to SARS-CoV-2 membrane protein in infected individuals strongly correlates with lung injury"],"prefix":"10.1038","volume":"14","author":[{"given":"Giovanni","family":"Faggioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Moramarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliana","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Petralito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orr","family":"Rozov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florigio","family":"Lista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"78381_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"20","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 20, 727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017 (2020).","journal-title":"N. Engl. J. Med."},{"key":"78381_CR2","doi-asserted-by":"publisher","unstructured":"Hu, B., Guo, H., Zhou, P. & Shi, Z. L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154. https:\/\/doi.org\/10.1038\/s41579-020-00459-7 (2021). Erratum in: Nat. Rev. Microbiol. 20, 315. https:\/\/doi.org\/10.1038\/s41579-022-00711-2 (2022).","DOI":"10.1038\/s41579-020-00459-7 10.1038\/s41579-022-00711-2"},{"key":"78381_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1126\/science.abm4915","volume":"11","author":"K Koelle","year":"2022","unstructured":"Koelle, K., Martin, M. A., Antia, R., Lopman, B. & Dean, N. E. The changing epidemiology of SARS-CoV-2. Science 11, 1116\u20131121. https:\/\/doi.org\/10.1126\/science.abm4915 (2022).","journal-title":"Science"},{"key":"78381_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"27","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 27, 450\u2013454. https:\/\/doi.org\/10.1038\/nature02145 (2003).","journal-title":"Nature"},{"key":"78381_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"7","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 7, 1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648 (2020).","journal-title":"JAMA"},{"key":"78381_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","volume":"64","author":"JJ Zhang","year":"2023","unstructured":"Zhang, J. J., Dong, X., Liu, G. H. & Gao, Y. D. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin. Rev. Allergy Immunol. 64, 90\u2013107. https:\/\/doi.org\/10.1007\/s12016-022-08921-5 (2023).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"78381_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/EC9.0000000000000026","volume":"2","author":"X Zhou","year":"2022","unstructured":"Zhou, X. et al. Clinical features of 162 fatal cases of COVID-19: A multi-center retrospective study. Emerg. Crit. Care Med. 2, 109\u2013115. https:\/\/doi.org\/10.1097\/EC9.0000000000000026 (2022).","journal-title":"Emerg. Crit. Care Med."},{"key":"78381_CR8","doi-asserted-by":"publisher","first-page":"e0243711","DOI":"10.1371\/journal.pone","volume":"15","author":"M Owusu","year":"2020","unstructured":"Owusu, M. et al. Epidemiological profile of SARS-CoV-2 among selected regions in Ghana: A cross-sectional retrospective study. PLoS ONE 15, e0243711. https:\/\/doi.org\/10.1371\/journal.pone (2020).","journal-title":"PLoS ONE"},{"key":"78381_CR9","unstructured":"www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"78381_CR10","doi-asserted-by":"publisher","first-page":"105108","DOI":"10.1016\/j.meegid.2021.105108","volume":"96","author":"G Faggioni","year":"2021","unstructured":"Faggioni, G. et al. Identification and characterization of SARS-CoV-2 clusters in the EU\/EEA in the first pandemic wave: Additional elements to trace the route of the virus. Infect. Genet. Evol. 96, 105108. https:\/\/doi.org\/10.1016\/j.meegid.2021.105108 (2021).","journal-title":"Infect. Genet. Evol."},{"key":"78381_CR11","doi-asserted-by":"publisher","unstructured":"Islam, M. R. et al. Author Correction: Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci. Rep. 11, 20568. https:\/\/doi.org\/10.1038\/s41598-021-00133-9 (2021). Erratum for: Sci. Rep. 10, 14004 (2020).","DOI":"10.1038\/s41598-021-00133-9"},{"key":"78381_CR12","doi-asserted-by":"publisher","first-page":"601886","DOI":"10.3389\/fimmu.2020","volume":"11","author":"F Tavasolian","year":"2021","unstructured":"Tavasolian, F. et al. HLA, immune response, and susceptibility to COVID-19. Front. Immunol. 11, 601886. https:\/\/doi.org\/10.3389\/fimmu.2020 (2021).","journal-title":"Front. Immunol."},{"key":"78381_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395, 565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8 (2020).","journal-title":"Lancet"},{"key":"78381_CR14","doi-asserted-by":"publisher","first-page":"e00028","DOI":"10.1128\/CMR.00028-20","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama, K. et al. Coronavirus disease 2019-COVID-19. Clin. Microbiol. Rev. 33, e00028. https:\/\/doi.org\/10.1128\/CMR.00028-20 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"78381_CR15","doi-asserted-by":"publisher","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","volume":"1866","author":"AAT Naqvi","year":"2020","unstructured":"Naqvi, A. A. T. et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165878. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165878 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"78381_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"M Romano","year":"2020","unstructured":"Romano, M., Ruggiero, A., Squeglia, F., Maga, G. & Berisio, R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 9, 1267. https:\/\/doi.org\/10.3390\/cells9051267 (2020).","journal-title":"Cells"},{"key":"78381_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. The architecture of SARS-CoV-2 transcriptome. Cell 181, 914\u2013921. https:\/\/doi.org\/10.1016\/j.cell.2020.04.011 (2020).","journal-title":"Cell"},{"key":"78381_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coviro.2021.11.011","volume":"52","author":"NJ Hardenbrook","year":"2022","unstructured":"Hardenbrook, N. J. & Zhang, P. A structural view of the SARS-CoV-2 virus and its assembly. Curr. Opin. Virol. 52, 123\u2013134. https:\/\/doi.org\/10.1016\/j.coviro.2021.11.011 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"78381_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (2020).","journal-title":"Cell"},{"key":"78381_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/v4040557","volume":"4","author":"T Heald-Sargent","year":"2012","unstructured":"Heald-Sargent, T. & Gallagher, T. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses 4, 557\u2013580. https:\/\/doi.org\/10.3390\/v4040557 (2012).","journal-title":"Viruses"},{"key":"78381_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","volume":"6","author":"NC Kyriakidis","year":"2021","unstructured":"Kyriakidis, N. C., L\u00f3pez-Cort\u00e9s, A., Gonz\u00e1lez, E. V., Grimaldos, A. B. & Prado, E. O. SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates. NPJ Vaccines 6, 28. https:\/\/doi.org\/10.1038\/s41541-021-00292-w (2021).","journal-title":"NPJ Vaccines"},{"key":"78381_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-023-01968-6","volume":"20","author":"W Wu","year":"2023","unstructured":"Wu, W., Cheng, Y., Zhou, H., Sun, C. & Zhang, S. The SARS-CoV-2 nucleocapsid protein: Its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6. https:\/\/doi.org\/10.1186\/s12985-023-01968-6 (2023).","journal-title":"Virol. J."},{"key":"78381_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058 (2020).","journal-title":"Cell"},{"key":"78381_CR24","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.3390\/ijms23062986","volume":"23","author":"C Marques-Pereira","year":"2022","unstructured":"Marques-Pereira, C. et al. SARS-CoV-2 membrane protein: From genomic data to structural new insights. Int. J. Mol. Sci. 23, 2986. https:\/\/doi.org\/10.3390\/ijms23062986 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"78381_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3c32::aid-cncr2820030106%3e3.0.co;2-3 (1950).","journal-title":"Cancer"},{"key":"78381_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ncrna.2023.02.007","volume":"8","author":"I Gilyazova","year":"2023","unstructured":"Gilyazova, I. et al. COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments. Noncoding RNA Res. 8, 240\u2013254. https:\/\/doi.org\/10.1016\/j.ncrna.2023.02.007 (2023).","journal-title":"Noncoding RNA Res."},{"key":"78381_CR27","doi-asserted-by":"publisher","first-page":"1130398","DOI":"10.3389\/fimmu.2023.1130398","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun, Y., Luo, B., Liu, Y., Wu, Y. & Chen, Y. Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic. Front. Immunol. 14, 1130398. https:\/\/doi.org\/10.3389\/fimmu.2023.1130398 (2023).","journal-title":"Front. Immunol."},{"key":"78381_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184, 861\u2013880. https:\/\/doi.org\/10.1016\/j.cell.2021.01.007 (2021).","journal-title":"Cell"},{"key":"78381_CR29","doi-asserted-by":"publisher","first-page":"152393","DOI":"10.1016\/j.imbio.2023.152393","volume":"228","author":"WM Zelek","year":"2023","unstructured":"Zelek, W. M. & Harrison, R. A. Complement and COVID-19: Three years on, what we know, what we don\u2019t know, and what we ought to know. Immunobiology 228, 152393. https:\/\/doi.org\/10.1016\/j.imbio.2023.152393 (2023).","journal-title":"Immunobiology"},{"key":"78381_CR30","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/eji.202048915","volume":"50","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni, A. et al. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Eur. J. Immunol. 50, 2013\u20132024. https:\/\/doi.org\/10.1002\/eji.202048915 (2020).","journal-title":"Eur. J. Immunol."},{"key":"78381_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/infdis\/jiaa463","volume":"222","author":"G Rijkers","year":"2020","unstructured":"Rijkers, G. et al. Differences in antibody kinetics and functionality between severe and mild severe acute respiratory syndrome coronavirus 2 infections. J. Infect. Dis. 222, 1265\u20131269. https:\/\/doi.org\/10.1093\/infdis\/jiaa463 (2020).","journal-title":"J. Infect. Dis."},{"key":"78381_CR32","doi-asserted-by":"publisher","unstructured":"Lucas, C. et al. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat. Med. 27, 1178\u20131186. https:\/\/doi.org\/10.1038\/s41591-021-01355-0 (2021). Erratum in: Nat. Med. 27, 1309. https:\/\/doi.org\/10.1038\/s41591-021-01416-4 (2021).","DOI":"10.1038\/s41591-021-01355-0 10.1038\/s41591-021-01416-4"},{"key":"78381_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","volume":"18","author":"V Legros","year":"2021","unstructured":"Legros, V. et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol. Immunol. 18, 318\u2013327. https:\/\/doi.org\/10.1038\/s41423-020-00588-2 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"78381_CR34","doi-asserted-by":"publisher","unstructured":"Abril, A. G. et al. Author Correction: Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection. Sci. Rep. 14, 15918. https:\/\/doi.org\/10.1038\/s41598-024-66711-9 (2024). Erratum for: Sci. Rep. 14, 12725. https:\/\/doi.org\/10.1038\/s41598-024-59634-y (2024).","DOI":"10.1038\/s41598-024-66711-9 10.1038\/s41598-024-59634-y"},{"key":"78381_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 600, 472\u2013477. https:\/\/doi.org\/10.1038\/s41586-021-03767-x (2021).","journal-title":"Nature"},{"key":"78381_CR36","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze, J. L. & Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell 184, 1671\u20131692. https:\/\/doi.org\/10.1016\/j.cell.2021.02.029 (2021).","journal-title":"Cell"},{"key":"78381_CR37","doi-asserted-by":"publisher","first-page":"105658","DOI":"10.1016\/j.micpath.2022.105658","volume":"169","author":"E Pereira","year":"2022","unstructured":"Pereira, E. et al. ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms. Microb. Pathog. 169, 105658. https:\/\/doi.org\/10.1016\/j.micpath.2022.105658 (2022).","journal-title":"Microb. Pathog."},{"key":"78381_CR38","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/infdis\/jiac263","volume":"28","author":"MF Amjadi","year":"2022","unstructured":"Amjadi, M. F. et al. Anti-membrane antibodies persist at least one year and discriminate between past coronavirus disease 2019 infection and vaccination. J. Infect. Dis. 28, 1897\u20131902. https:\/\/doi.org\/10.1093\/infdis\/jiac263 (2022).","journal-title":"J. Infect. Dis."},{"key":"78381_CR39","doi-asserted-by":"publisher","first-page":"4389089","DOI":"10.1155\/2020\/4389089","volume":"2020","author":"M Bianchi","year":"2020","unstructured":"Bianchi, M. et al. Sars-CoV-2 envelope and membrane proteins: Structural differences linked to virus characteristics?. Biomed. Res. Int. 2020, 4389089. https:\/\/doi.org\/10.1155\/2020\/4389089 (2020).","journal-title":"Biomed. Res. Int."},{"key":"78381_CR40","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/ijms22031308","volume":"22","author":"NA Wong","year":"2021","unstructured":"Wong, N. A. & Saier, M. H. The SARS-coronavirus infection cycle: A survey of viral membrane proteins, their functional interactions and pathogenesis. Int. J. Mol. Sci. 22, 1308. https:\/\/doi.org\/10.3390\/ijms22031308 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"78381_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41418-022-00928-x","volume":"29","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ. 29, 1395\u20131408. https:\/\/doi.org\/10.1038\/s41418-022-00928-x (2022).","journal-title":"Cell Death Differ."},{"key":"78381_CR42","doi-asserted-by":"publisher","first-page":"1332440","DOI":"10.3389\/fimmu.2024.1332440","volume":"15","author":"G Zheng","year":"2024","unstructured":"Zheng, G., Qiu, G., Qian, H., Shu, Q. & Xu, J. Multifaceted role of SARS-CoV-2 structural proteins in lung injury. Front. Immunol. 15, 1332440. https:\/\/doi.org\/10.3389\/fimmu.2024.1332440 (2024).","journal-title":"Front. Immunol."},{"key":"78381_CR43","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/jleuko\/qiae017","volume":"115","author":"D Fern\u00e1ndez-Soto","year":"2024","unstructured":"Fern\u00e1ndez-Soto, D. et al. SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virus. J. Leukoc. Biol. 115, 985\u2013991. https:\/\/doi.org\/10.1093\/jleuko\/qiae017 (2024).","journal-title":"J. Leukoc. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78381-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T02:02:49Z","timestamp":1735351369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78381"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78381-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30665"}}